A Novel Statistical Prognostic Score Model That Includes Serum CXCL5 Levels and Clinical Classification Predicts Risk of Disease Progression and Survival of Nasopharyngeal Carcinoma Patients

CXCL5 Promotes Prostate Cancer Progression

(2015) Lesa A Begley et al.   NEOPLASIA

Overexpression of CXCL5 Is Associated With Poor Survival in Patients With Pancreatic Cancer

(2011) Aihua Li et al.   AMERICAN JOURNAL OF PATHOLOGY

To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area

(2011) Y. Jin et al.   EUROPEAN JOURNAL OF CANCER

CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer

(2011) Mikio Kawamura et al.   EUROPEAN JOURNAL OF CANCER

Prognosticators and Risk Grouping in Patients with Lung Metastasis from Nasopharyngeal Carcinoma: A more accurate and appropriate assessment of prognosis

(2011) Xun Cao et al.   Radiation Oncology

Serum CCL2 and serum TNF-α – Two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma

(2010) Xing Lu et al.   EUROPEAN JOURNAL OF CANCER

How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?

(2010) Shu-Zhen Lai et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway

(2010) Po-Lin Kuo et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Serologic Antienzyme Rate of Epstein-Barr Virus DNase-Specific Neutralizing Antibody Segregates TNM Classification in Nasopharyngeal Carcinoma

(2010) Jie Xu et al.   JOURNAL OF CLINICAL ONCOLOGY

Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration

(2009) K Endo et al.   ONCOGENE

Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells

(2008) Chih-Yeu Fang et al.   INTERNATIONAL JOURNAL OF CANCER